Skip to main content
Publications
Chang J, Ngai C, Odom DM , Radder CN, Kappeler C, Xu R, Qin S, Kim T, Li J. Effects of regorafenib (REG) therapy on health-related quality of life (HRQoL) in patients with metastatic colorectal cancer (mCRC) in the phase III CONCUR trial . Poster presented at the 2015 ASCO Annual Meeting; May 29, 2015. Chicago, IL.
Stenehjem DD, Tyczynski JE, Unni SK, Bauer H, Sainski A, Deka R, Shauehamer M, Gutierrez LP , Kaye JA, Telford C, Brixner DI, Biskupiak DI. Evaluation of BRCA mutation (BRCAm) testing patterns, clinical characteristics and overall survival (OS) in breast cancer (BC) patients over a 20-year period . J Clin Oncol. 2015 May 29;33(15_suppl):e12518. doi: 10.1200/jco.2015.33.15_suppl.e12518
Kohlmeier M, Dong OM . Nutrigenetics in practice . Presented at the 2015 Congress of the International Society of Nutrigenetics & Nutrigenomics; May 17, 2015. Chapel Hill, NC.
Rottenkolber M, Fischer R, Ibanez L, Fortuny J , Reynolds R, Amelio J, Gerlach R, Tauscher M, Thurmann P, Hasford J, Schmiedl S. Prescribing of long-acting beta-2-agonists/inhaled corticosteroids after the SMART trial . BMC Pulm Med. 2015 May 6;15:55.
Quteineh L, Vandenberghe F, Saigi Morgui N , Delacretaz A, Choong E, Gholam-Rezaee M, Magistretti P, Bondolfi G, von Gunten A, Preisig M, Castelao E, Vollenweider P, Waeber G, Bochud M, Kutalik Z, Conus P, Eap CB. Impact of HSD11B1 polymorphisms on BMI and components of the metabolic syndrome in patients receiving psychotropic treatments . Pharmacogenet Genomics. 2015 May;25(5):246-58. doi: 10.1097/FPC.0000000000000131
Williams V , Coles T, DeMuro C , Lewis S , Williams N, Yarr S , Barghout V, Lowes L, Alfano L, Goldberg B, Gnanasakthy A , Tseng B. Psychometric evaluation of the Sporadic Inclusion Body Myositis (sIBM) Physical Functioning Assessment (sIFA) . Poster presented at the 1st Annual International Conference on Myositis; May 2015. Stockholm, Sweden.
Hogue SL, Bennett ME, Goss DS , Hollis KA , Millar K, Silvia S, Siegel P, Wolf R, Wooddell M, White MV. Availability and use of epinephrine auto-injectors for the treatment of anaphylaxis: results from the EpiPen4Schools® survey . Poster presented at the 2015 ISPOR 20th Annual International Meeting; May 2015. Philadelphia, PA. [abstract] Value Health. 2015 May; 18(3):A178. doi: 10.1016/j.jval.2015.03.1030
Mladsi DM , Goyal RK , Cryer B, Hopkins WE, Brater CD, Korsnes JS, Candrilli SD , Castellsague J, Varas-Lorenzo C. Risk of cardiovascular, gastrointestinal, and renal adverse events associated with diclofenac immediate and extended release drug products: an observational study using US claims data . Poster presented at the 2015 ISPOR 20th Annual International Meeting; May 2015. Philadelphia, PA. [abstract] Value Health. 2015 May; 18(3):A292.
Mahida SR , Seoane E, Klinger E, Salazar A, HER QL, Medoff J, Amato M, Dykes PC, Haas J, Bates D, Schiff G. Cost of reporting possible adverse drug reactions in medical outpatients using a telephonic interactive voice response system . Poster presented at the 2015 ISPOR 20th Annual International Meeting; May 20, 2015. Philadelphia, PA. [abstract] Value Health. 2015 May 1; 18(3):PA257. doi: 10.1016/j.jval.2015.03.1498
Nastoupil LJ, Sinha R, Byrtek M, Ziemiecki R , Taylor M, Friedberg JW, Koff JL, Link BK, Cerhan JR, Dawson KL, Flowers CR. Comparison of the effectiveness of frontline chemoimmunotherapy regimens for follicular lymphoma used in the United States . Leuk Lymphoma. 2015 May;56(5):1295-302. doi: 10.3109/10428194.2014.953144